OPTX

Syntec Optics is a small vertically-integrated optics manufacturer (defense, medical, consumer, communications) with a genuinely differentiated polymer-optics niche — but the business is stagnant, not growing. Revenue has gone $27.8M → $29.4M → $28.4M → $28.1M over FY2022-2025, a four-year round-trip to nowhere, with FY2025 down 1.3% YoY. The company has posted a GAAP net loss in three of those four years (FY2025 -$1.79M, net margin -6.4%, ROE -18.8%), and the one profitable year (FY2023) looks like the outlier, not the trend. Gross margin of 23.3% is thin for a 'sub-micron tolerance' specialist and operating income is still negative (-$518K). This is a fine little manufacturing shop, not a compounder.

The problem is the price. At $10.88 the market caps this at $402M — 14.3x trailing sales on a business that isn't growing and doesn't earn money. That multiple is reserved for high-growth software or semis; slapping it on a $28M-revenue optics job-shop with flat sales is a valuation error waiting to correct. There is no earnings multiple to lean on (EPS is -$0.05), so the entire thesis for owning it here is that silicon-photonics / LEO-satellite / night-vision optics narrative re-rates revenue upward — and there is zero evidence of that inflection in the actual numbers yet.